Asia Green Biotechnology Corp.
ASIA
CNSX
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -61.81% | 149.41% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -61.81% | 149.41% | |||
| Operating Income | 61.81% | -149.41% | |||
| Income Before Tax | 59.11% | -129.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 59.11% | -129.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 59.11% | -129.53% | |||
| EBIT | 61.81% | -149.41% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 59.09% | -144.44% | |||
| Normalized Basic EPS | 57.14% | -133.33% | |||
| EPS Diluted | 59.09% | -144.44% | |||
| Normalized Diluted EPS | 57.14% | -133.33% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||